Synthesis, structural characterisation and biological evaluation of fluorinated analogues of resveratrol

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 13, 2009, Pages 4510-4522

  Moran, Brian W ^a   Anderson, Frankie P ^a   Devery, Aoife ^a   Cloonan, Stephen ^a   Butler, William E ^a   Varughese, Sunil ^b   Draper, Sylvia M ^b   Kenny, Peter T M ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Fluorine; Nitro, Amine, Anticancer; Resveratrol; Stilbene

Indexed keywords

3,4',5 TRIFLUOROSTILBENE; 3,5 DI(TRIFLUOROACETYLAMINO) 4' FLUOROSTILBENE; 3,5 DIFLUORO 4' ACETOXYSTILBENE; 3,5 DIFLUORO 4' METHOXYSTILBENE; 3,5 DIMETHOXY 4' FLUOROSTILBENE; EPIRUBICIN; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; DRUG SYNTHESIS; FLUORINATION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MELANOMA CELL;

ANTIBIOTICS, ANTINEOPLASTIC; ANTICARCINOGENIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; EPIRUBICIN; HALOGENATION; HUMANS; MOLECULAR STRUCTURE; NEOPLASMS; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP;

VITACEAE;

EID: 66449085994     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.05.007     Document Type: Article

References (27)

1. Katiyar S.K., and Elmets C.A. Int. J. Oncol. 18 (2001) 1307
2. Wang J., Shang F., Liu L., Wang S., Wang J., and Mei Q. Indian J. Pharmacol. 39 (2007) 103
3. Roberti M., Pizzirani D., Simoni D., Rondanin R., Baruchello R., Bonora C., Buscemi F., Grimaudo S., and Tolomeo M. J. Med. Chem. 46 (2003) 3546
4. Waffo-Teguo P., Hawthorne M.E., Cuendet M., Merillon J.M., Kingharn A.D., Pezzuto J.M., and Mehta R.G. Nutr. Cancer 40 (2001) 173
5. Lee H.J., Seo J.W., Lee B.H., Chung K.H., and Chi D.Y. Bioorg. Med. Chem. Lett. 14 (2004) 463
6. Pettit G.R., Grealish M.P., Jung K., Hamel E., Pettit R.K., Chapuis J.C., and Schmidt J.M. J. Med. Chem. 45 (2002) 2534
7. Botella L., and Nájera C. Tetrahedron 60 (2004) 5563
8. Whitesell L., Mimnaugh E.G., De Costa B., Myers C.E., and Neckers L.M. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8324
9. Savouret J.F., and Quesne M. Biomed. Pharmacother. 56 (2002) 84
10. Milner J.A., McDonald S.S., Anderson D.E., and Greenwald P. Nutr. Cancer 41 (2001) 1
11. Chan M.M.Y. Biochem. Pharmacol. 63 (2002) 99
12. Romero-Pérez A.I., Lameula-Raventós R.M., Andrés-Laceuva C., and de La Torre-Boronat M.C. J. Agric. Food Chem. 49 (2001) 210
13. Ferré-Filmon K., Delaude L., Demonceau A., and Noels A.F. Coord. Chem. Rev. 248 (2004) 2323
14. Andrus M.B., and Liu J. Tetrahedron Lett. 47 (2006) 5811
15. Andrus M.B., Liu J., Meredith E.L., and Nartey E. Tetrahedron Lett. 44 (2003) 4819
16. Ramesh C., Mahender G., Ravindranath N., and Das B. Tetrahedron 59 (2003) 1049
17. McCarroll, A. Synthetic Pages 2007, 261. http://www.syntheticpages.org/search.php?&action=1&page=1&id=261.
18. Corry A.J., Goel A., Alley S.R., Kelly P.N., O'Sullivan D., Savage D., and Kenny P.T.M. J. Organomet. Chem. 692 (2007) 1405
19. Savage D., Alley S.R., Goel A., Hogan T., Ida Y., Kelly P.N., Lehmann L., and Kenny P.T.M. Inorg. Chem. Commun. 9 (2006) 1267
20. Kobayashi Y., Furukawa-Hibi Y., Chen C., Horio Y., Isobe K., Ikeda K., and Motoyama N. Int. J. Mol. Med. 2 (2005) 237
21. Athar M., Back J.H., Tang X., Kim K.H., Kopelovich L., Bickers D.R., and Kim A.L. Toxicol. Appl. Pharmacol. 224 (2007) 274
22. De la Castra C.A., and Villegas I. Biochem. Soc. Trans. 35 (2007) 1156
23. Heenan M., O'Driscoll L., Cleary I., Connelly L., and Clynes M. Int. J. Cancer 5 (1997) 907
24. Yang T.-T., Sinai P., and Kain S.R. Anal. Biochem. 241 (1996) 103
25. Babich H., Reisbaum A.G., and Zuckerbraun H.L. Toxicol. Lett. 114 (2000) 143
26. De Medina P., Casper P., Savouret J.F., and Poirot M. J. Med. Chem. 48 (2005) 287
27. Lion C.J., Matthews C.S., Stevens M.F.G., and Westwell A.D. J. Med. Chem. 48 (2005) 1292